| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 705.84 Million |
| Market Size (2030) | USD 929.08 Million |
| CAGR (2025 - 2030) | 5.65 % |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Japan Magnetic Resonance Imaging Market Analysis
The Japan Magnetic Resonance Imaging Market size is estimated at USD 705.84 million in 2025, and is expected to reach USD 929.08 million by 2030, at a CAGR of 5.65% during the forecast period (2025-2030).
The COVID-19 pandemic has sparked the disturbance of long-established practices in an extremely short period. Issues such as climate change and other infectious diseases are set to cause even worse crises and new societal risks in the future. It has had a significant impact on stroke healthcare, including the prehospital care system and in-hospital workflow. Before the COVID-19 pandemic, brain MRI was mainly used to evaluate the indication for reperfusion therapy according to the institutional policy. After the lifting of the State of Emergency in the With-COVID-19 period, the proportion of patients undergoing MRI increased, especially in patients who only received intravenous thrombolysis. Therefore, it is observed that the use of MRI imaging significantly increased, which, in turn, boosted the growth of the MRI market in Japan.
According to a study titled 'Acute Ischemic Stroke During the Convalescent Phase of Asymptomatic COVID-2019 Infection in Men', published in April 2021, acute ischemic stroke (AIS) is a documented neurological consequence in COVID-19 infected patients who have respiratory symptoms. AIS, on the other hand, has not been recorded as a late complication in COVID-19 individuals who do not have respiratory symptoms. The results from the clinical course, imaging, and laboratory findings were retrieved and compared. The incidence rate is high in COVID-positive patients, which is expected to increase the demand for diagnostic imaging and the MRI market in Japan.
Some of the major factors driving the market growth include the rising burden of chronic diseases, increasing demand for diagnostic imaging, and the presence of key Magnetic Resonance Imaging manufacturers in the country. Furthermore, Japan is a research-intensive country, and research studies in the area of Magnetic Resonance Imaging systems are expected to advance the MRI technology and increase awareness. For instance, according to a research study published in September 2021, titled 'Comparison of Diagnostic Accuracy for TNM Stage Among Whole-Body MRI and Coregistered PET/MRI Using 1.5-T and 3-T MRI Systems and Integrated PET/CT for Non-Small Cell Lung Cancer', whole-body MRI and coregistered PET/MRI using 3-T and 1.5-T MRI systems are as accurate or more accurate than PET/CT, whereas differences between 3-T and 1.5-T MRI systems are not considered significant. Therefore, the Magnetic Resonance Imaging market in Japan is expected to witness strong growth over the forecast period.
Japan Magnetic Resonance Imaging Market Trends
Oncology Segment is Expected to Witness Significant Growth in Future
Magnetic Resonance Imaging (MRI) is an imaging test that can be used for the detection of tumor/cancerous cells in the body and to look for signs that cancer may have metastasized (spread) from where it started to another part of the body. An MRI system uses powerful magnets and radio waves to make detailed, computer-generated cross-sectional images of the body, which are later used by doctors in the diagnosis of cancerous cells/tissue.
Japan is one of the most technologically advanced countries in the Asia-Pacific region and has a robust healthcare system with a high burden of cancer, which is driving the growth of medical imaging technologies in oncology in the country. For instance, according to the Globocan 2020 report, Japan reported 1,028,658 new cases of cancer in 2020, and the total number of five-year prevalent cases of cancer was 2,710,728. The major forms of cancer, which were majorly diagnosed in the country in both sexes were colorectum, lung, stomach, prostate, and breast cancer. Further, as per the above-mentioned source, it is projected that the cases of cancer will reach 1,110,549 by 2030, and 1,128,057 by 2040 in Japan, which will further increase the demand for MRI systems in the country and drive the growth of the oncology segment.
According to a research study published in June 2021, titled 'Interval Cancers after Negative Supplemental Screening Breast MRI Results in Women with a Personal History of Breast Cancer', the cancer detection rate was 8.3 per 1000 screening examinations, the interval cancer rate was 1.5 per 1000 screening examinations, and the multivariable analysis, interval cancers were associated with a first-degree family history of breast cancer, estrogen receptor- and progesterone receptor-negative primary cancers, and moderate or marked background parenchymal enhancement, which suggests the hereditary linkage of breast cancer, which might lead to a high number of breast cancer, propelling the segment toward growth.
Understand The Key Trends Shaping This Market
Download PDF
Japan Magnetic Resonance Imaging Industry Overview
The Japan Magnetic Resonance Imaging market is highly competitive and consists of several major Magnetic Resonance Imaging manufacturers. In terms of market share, a few of the major players currently dominate the market. However, with technological advancements such as portable MRI and open MRI systems, mid-size to smaller companies are increasing their market presence by introducing new products at lower prices. Companies like Siemens Healthineers, GE Healthcare, Canon Medical Systems, and Philips Healthcare hold a significant market share in the global Magnetic Resonance Imaging market.
Japan Magnetic Resonance Imaging Market Leaders
-
Siemens AG
-
Canon Medical Systems
-
GE Healthcare
-
Fujifilm Holidngs Corporation
-
Koninklijke Philips N.V.
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF
Japan Magnetic Resonance Imaging Market News
- In December 2021, Canon Medical Systems Corp, l, a Japan-based company, signed a licensing arrangement with Resoundant Inc. to include its technology in Canon's newest line of magnetic resonance imaging. Although research is underway to use Resoundant's MRE technology to scan other soft organs and brains.
- In November 2021, Canon Medical launched the Vantage Fortian, a new open bore 1.5T MRI system with advanced productivity. The new system includes unique workflow solutions, image enhancement, and expedited scan technologies, all of which can help to reduce MRI process times.
Japan Magnetic Resonance Imaging Industry Segmentation
As per the scope of this report, magnetic resonance imaging is a medical imaging technique, which is used in radiology to produce pictures of the anatomy and the physiological processes of the body. These pictures are further used to diagnose and detect the presence of abnormalities in the body. Japan Magnetic Resonance Imaging (MRI) Market is segmented by Architecture (Closed MRI Systems and Open MRI Systems), Field Strength (Low Field MRI Systems, High Field MRI Systems, Very High Field MRI Systems and Ultra-high MRI Systems), Application (Oncology, Neurology, Cardiology, Gastroenterology, Musculoskeletal, and Other Applications). The report offers the value (in USD million) for the above segments.
| By Architecture | Closed MRI Systems |
| Open MRI Systems | |
| By Field Strength | Low Field MRI Systems |
| High Field MRI Systems | |
| Very High Field MRI Systems and Ultra-high MRI Systems | |
| By Application | Oncology |
| Neurology | |
| Cardiology | |
| Gastroenterology | |
| Musculoskeletal | |
| Other Applications |
Need A Different Region or Segment?
Customize Now
Japan Magnetic Resonance Imaging Market Research FAQs
How big is the Japan Magnetic Resonance Imaging Market?
The Japan Magnetic Resonance Imaging Market size is expected to reach USD 705.84 million in 2025 and grow at a CAGR of 5.65% to reach USD 929.08 million by 2030.
What is the current Japan Magnetic Resonance Imaging Market size?
In 2025, the Japan Magnetic Resonance Imaging Market size is expected to reach USD 705.84 million.
Who are the key players in Japan Magnetic Resonance Imaging Market?
Siemens AG, Canon Medical Systems, GE Healthcare, Fujifilm Holidngs Corporation and Koninklijke Philips N.V. are the major companies operating in the Japan Magnetic Resonance Imaging Market.
What years does this Japan Magnetic Resonance Imaging Market cover, and what was the market size in 2024?
In 2024, the Japan Magnetic Resonance Imaging Market size was estimated at USD 665.96 million. The report covers the Japan Magnetic Resonance Imaging Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Japan Magnetic Resonance Imaging Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Japan Magnetic Resonance Imaging Industry Report
Statistics for the 2025 Japan Magnetic Resonance Imaging market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Japan Magnetic Resonance Imaging analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
